Current Status of New Anticoagulants in the Management of Venous Thromboembolism

Abstract

Venous Thromboembolism, manifested as deep venous thrombosis and pulmonary embolism, is a common problem associated with significant morbidity, mortality, and resource expenditure. Unfractionated heparin, low-molecular-weight heparin, and vitamin K antagonists are the most common treatment and prophylaxis, and have demonstrated their efficacy in a vast… (More)
DOI: 10.1155/2012/856341

Topics

  • Presentations referencing similar topics